AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E400535-T1: [Translated] ROLLER AND ROTARY DRIVE DEVICE

The invention relates to a roller ( 21 ) from a refractory material, for example in vitreous silica, for transporting a flat article provided at its end with a new arrangement for rotationally driving it as well as to an assembly of such a roller and its driving device. This roller ( 21 ) comprises an external surface ( 2 ), an inner surface ( 5 ) and two side surfaces ( 12 ), at least one side surface having indentations ( 22 ) parallel to the roller axis ( 3 ) and spaced apart from the external ( 2 ) and inner surface ( 5 ) for receiving rotationally driving pins ( 8 ), it is characterized in that at least one of the indentations ( 22 ) of the roller is provided with a metal jacket ( 24 ). The invention permits to avoid the breakage of the roller around the driving indentations.
Compound 527718: Isobutyl 3-bromopropanoate

Chemical compound data from PubChem database. IUPAC Name: 2-methylpropyl 3-bromopropanoate. Molecular Formula: C7H13BrO2. Molecular Weight: 209.08. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Past Year Mental Disorders among Adults in the United States: Results from the 2008-2012 Mental Health Surveillance Study

This report presents estimates of the numbers and percentages of adults aged 18 or older with past 12-month mental disorders, as assessed by the Mental Health Surveillance Study (MHSS) clinical study, a subset to the 2008 to 2012 National Survey of Drug Use and Health (NSDUH). The assessment included a modified version of the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I). The assessed disorders included mood disorders; anxiety disorders, including obsessive compulsive disorder [OCD], and posttraumatic stress disorder [PTSD]; substance use disorders; eating disorders; other disorders; and a screener for psychotic symptoms. Results are presented by gender, age group, race/ethnicity, family income, education, county type, poverty level, employment, marital status, Census region, and health insurance coverage.
Compound 526343: 2-Bromo-1,3,7,9-tetrachlorodibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 2-bromo-1,3,7,9-tetrachlorodibenzo-p-dioxin. Molecular Formula: C12H3BrCl4O2. Molecular Weight: 400.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Climate Shield Cutthroat Trout (0% Brook Trout), 2040 (Feature Layer)

This feature class represents the mid-century (2030-2059) scenario for cutthroat trout, derived from the Climate Shield fish distribution models. These models provide stream-specific probabilistic predictions about the occurrence of juvenile bull trout and cutthroat trout in association with three different scenarios for climate change and brook trout invasions. These datasets indicate all potential cold-water habitats less than 11 degrees Celsius. The attribute fields CT_0BRK - CT_100BRK indicate the probabilities of cutthroat trout occurrence within a cold-water habitat based on the prevalence of brook trout at 0%, 25%, 50%, 75%, or 100% of the sites within a habitat. The probabilities were predicted using the Climate Shield native trout models developed from known species occurrence in greater than 500 cold-water streams. The stream centerlines were based on the National Hydrography Dataset (NHD) but were modified for purposes of modeling and cross-walking to other datasets.
February Office Hours: Participation in the Pilot and Use of NCWDMS for AFCARS 2020 Reporting

The Children's Bureau Data Analytics and Reporting Team held their second AFCARS Open Office Hours for 2023. These sessions are for state and tribal program administrators, child welfare data leaders, and information system programmers. It provides an opportunity to ask questions specific to your agency's implementation of AFCARS 2020. The February session covered the recent changes in Technical Bulletins 20, 21, 22, and 23, as well as additional information presented by the NCWDMS team on how to participate in the pilot and use the National Child Welfare Data Management System (NCWDMS) for AFCARS 2020 reporting.

Metadata-only record linking to the original dataset. Open original dataset below.
Antenatal screening and its possible meaning from unborn baby's perspective

In recent decades antenatal screening has become one of the most routine procedure of pregnancy-follow up and the subject of hot debate in bioethics circles. In this paper the rationale behind doing antenatal screening and the actual and potential problems that it may cause will be discussed. The paper will examine the issue from the point of wiew of parents, health care professionals and, most importantly, the child-to-be. It will show how unthoughtfully antenatal screening is performed and how pregnancy is treated almost as a disease just since the emergence of antenatal screening. Genetic screening and ethical problems caused by the procedure will also be addressed and I will suggest that screening is more to do with the interests of others rather than those of the child-to be.
NCHS Survey Data Linked to Department of Veterans Affairs Administrative Data Files

NCHS has linked 2005-2018 National Health Interview Survey (NHIS) and 2005-2018 National Health and Nutrition Examination Survey (NHANES) to Department of Veterans Affairs (VA) administrative data through fiscal year 2020. Linkage of NCHS survey participants with VA administrative data provides the opportunity to examine a wide range of health-related topics for Veterans, including Veteran status and utilization of VA benefit programs.
Compound 528568: Arachidic acid, TBDMS

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] icosanoate. Molecular Formula: C26H54O2Si. Molecular Weight: 426.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2023 National Substance Use and Mental Health Services Survey (N-SUMHSS) Detailed Tables

The Annual Detailed Tables present in-depth findings on location, characteristics, and utilization of substance use and mental health services as collected by the National Substance Use and Mental Health Survey (N-SUMHSS). The data presented are intended to provide behavioral health services providers; researchers; and federal, state, and local governments with information about the number and characteristics of public and private substance use and mental health treatment facilities nationwide.
Compound 528980: 1,2-Hexadecanediol, 2-methyl, di-TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl-(2-methyl-1-trimethylsilyloxyhexadecan-2-yl)oxysilane. Molecular Formula: C23H52O2Si2. Molecular Weight: 416.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530049: Methyl 17-hydroxy-3-oxoandrost-4-ene-17-carboxylate

Chemical compound data from PubChem database. IUPAC Name: methyl 17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carboxylate. Molecular Formula: C21H30O4. Molecular Weight: 346.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525159: Glycerol-tripropylene glycol ether, triacetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-(2,3-diacetyloxypropoxy)propoxy]propoxy]propyl acetate. Molecular Formula: C18H32O9. Molecular Weight: 392.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
SHIP Adolescents Who Received A Wellness Checkup In The Last Year 2010-2021

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024

Adolescents Who Received A Wellness Checkup In The Last Year - This indicator reflects the percentage of adolescents (ages 13-20 years old) enrolled in Medicaid (320+ days) who received at least one well child visit during the past year. Adolescents are at heightened risk for a variety of poor health outcomes associated with: violence (homicide/suicide/intimate partner); injuries (motor vehicle/occupational/sports related); substance use and abuse; sexually transmitted infections, including HIV; unplanned pregnancies and homelessness. Well child visits provide the opportunity for health care providers to engage in primary, secondary, and tertiary prevention of poor health outcomes associated with these factors resulting in prevention, early detection, and treatment for issues that can otherwise have a life-long devastating impact on individuals. <a href ="https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/Adolescents%20who%20received%20a%20Wellness%20Checkup%20in%20the%20Last%20Year.pdf" > Link to Data Details </a>
National Survey of Substance Abuse Treatment Services (N-SSATS-2010)

<p>The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, to update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), to analyze general treatment services trends, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator <a href="http://findtreatment.samhsa.gov.Data">http://findtreatment.samhsa.gov.Data</a> are collected on topics including facility operation, services offered (assessment, testing, transitional, ancillary, and pharmacotherapies), detoxification, primary focus (substance abuse, mental health, both, general health, and other), Opioid Treatment Programs and medication dispensed/prescribed, counseling and therapeutic approaches, standard operating procedures, special programs/groups offered, languages in which treatment is provided, type of treatment provided (hospital inpatient, residential, outpatient), number of clients (by service, total, and under age 18), number of beds, types of payment accepted, sliding fee scale, and facility accreditation and licensure/certification.This study has 1 Data Set.</p>
Publications Using SAMHSA DataState and Substate Estimates of Serious Mental Illness from the 2012–2014 National Surveys on Drug Use and Health

This report provides state and substate estimates of serious mental illness among adults aged 18 or older using combined 2012-2014 National Survey on Drug Use and Health data. Estimates are provided for the nation as a whole and for each state and substate areas. Comparisons are made to estimates from 2010–2012.
Medical therapy versus interventional therapy in hypertropic obstructive cardiomyopathy

Medical treatment in symptomatic patients with hypertrophic obstructive cardiomyopathy aims to reduce the outflow tract gradients, and to improve diastolic dysfunction and rhythm disorders. Surgical myectomy is the standard treatment in patients with drug refractory symptoms. Since the early 1990s, dual-chamber (DDD)-pacemaker implantation and percutaneous transluminal septal myocardial ablation by alcohol-induced septal branch occlusion have widened treatment options in this subgroup of patients. An overview of medical and interventional treatment is presented.
Information Memorandum (IM-86-19)

This Information Memorandum (IM) establishes FY 1986 allotments for title IV-B and procedures for applying for: (1) A state's share of funds available under title IV-B in FY 1986; (2) Reallotted IV-B funds; and (3) Funds to be transferred from title IV-3-Foster Care.

Metadata-only record linking to the original dataset. Open original dataset below.
2013 CMHS Uniform Reporting System (URS) Tables Alabama

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Alabama for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 529368: Phe, N-isoBOC TBDMS

Chemical compound data from PubChem database. IUPAC Name: [tert-butyl(dimethyl)silyl] 2-(2-methylpropoxycarbonylamino)-3-phenylpropanoate. Molecular Formula: C20H33NO4Si. Molecular Weight: 379.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
TEDS Substance Abuse Treatment Admissions by Primary Substance of Abuse, According to Sex, Age Group, Race, and Ethnicity Tables 2013

This a Treatment Episode Data Set (TEDS) data table displaying substance abuse treatment admissions by primary substance abuse, according to sex, age group, race, and ethnicity. The Treatment Episode Data Set (TEDS) is a national data system of annual admissions to substance abuse treatment facilities. TEDS received treatment admission records from 46 states, the District of Columbia, and Puerto Rico in 2013.
Virginia 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Nursing Home Cost Report (RHCF): 2021

The Nursing Home Cost Report (RHCF) is a uniform report completed by New York nursing homes to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations (Part 86-2.2), nursing homes are required to file financial and statistical data with DOH annually. The data filed is part of the cost report and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends.
Compound 527228: 2,6,6,7-Tetramethyltricyclo[5.2.2.01,5]undecan-8-one

Chemical compound data from PubChem database. IUPAC Name: 2,6,6,7-tetramethyltricyclo[5.2.2.01,5]undecan-8-one. Molecular Formula: C15H24O. Molecular Weight: 220.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400421-T1: [Translated] HELMET, HELMET LINING WITH UNDERCUT AND PRODUCTION PROCESS THEREOF

This invention relates to a helmet, comprising an external shell (9) and an impact-absorbing helmet liner (10) in which the helmet liner comprises a layer provided with protruding, deformable and impact-absorbing hollow knobs (7) distributed on an substantial part of the surface of the helmet liner as a protective layer. The helmet is characterized in that the hollow knots (7) are arranged for deformation by crushing in case of external impact on the helmet, and that the helmet liner (10) with the hollow knots (7) exhibits undercut. The helmet may also comprise an impact-absorbing and preferably resilient layer (2) which may be arranged between the external shell (9) and an internal lining (11) being arranged to rest in contact with the head of a user.
Compound 526815: 17-Hydroxy-arachidic, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 17-[tert-butyl(dimethyl)silyl]oxyicosanoate. Molecular Formula: C27H56O3Si. Molecular Weight: 456.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529751: (2,7,7-Trimethyl-6-bicyclo[3.1.1]hept-2-enyl) pentanoate

Chemical compound data from PubChem database. IUPAC Name: (2,7,7-trimethyl-6-bicyclo[3.1.1]hept-2-enyl) pentanoate. Molecular Formula: C15H24O2. Molecular Weight: 236.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Vital Statistics Percent Early or Late/No Prenatal Care by Mother's Age and Resident County: Beginning 2008

This dataset contains the percentage of New York State live births with early prenatal care and late or no prenatal care by the mother’s age and county of residence.  The data presented here may not be the same as the Vital Statistics tables on the DOH public web due to data updates.  For more information, go to: http://www.health.ny.gov/statistics/vital_statistics/. The "About" tab contains additional details concerning this dataset.
Patent AT-E399510-T1: [Translated] IMPLANTABLE SQUISH MUSCLE PROSTHESIS SYSTEM, ESPECIALLY FOR USE IN THE AREA OF THE ANAL CANAL

An implantable muscle closing prosthesis system, particularly for opening and closing the rectum, characterized in that it has a compression unit, which comprises a compression cuff (1) and a reservoir cuff (2) molded as hollow bodies, and may integrate a bidirectional micropump (4) of arbitrary construction via a support ring (3), the cuffs primarily being subjected to a material compression during the inflation and deflation and communicating with one another via the micropump (4), which may be activated using a separate control unit, or is also manually operable from the outside.
Famciclovir

Famciclovir is a generic antiviral medication used to treat herpes infections, such as genital herpes, cold sores, and shingles. It works by inhibiting viral DNA replication. Available as oral tablets in 125mg, 250mg, and 500mg strengths, manufactured by Aurobindo Pharma Ltd. and Rising Pharma Holdings, Inc. This information was generated using AI and is provided for informational and research purposes only.
CFSR Technical Bulletin #12

This Technical Bulletin (TB) announces the next round of reviews the Children's Bureau plans to begin in federal fiscal year 2022. The bulletin provides a high-level overview of the reviews, outlines improvements to strengthen the CFSR process, and provides information on the scheduling of reviews for CFSR Round 4. The Children's Bureau will provide future guidance and hold calls with states to share more information about the process and procedures before the start of the reviews.

Metadata-only record linking to the original dataset. Open original dataset below.
Pacing in congestive heart failure

Despite the major advances in medical drug therapy, heart failure remains a syndrome associated with high mortality and morbidity. Biventricular or left ventricular (LV) short atrioventricular (AV) delay pacing is being tested in congestive heart failure patients with left bundle branch block. The aim is to resynchronise the dyscoordinate LV contraction. A number of studies are underway, but it is clear that while some patients respond remarkably, this is highly variable. Accurate identification of patients likely to benefit will be crucial. The mechanism of benefit is unclear. A greater understanding of the physiological consequences of pacing will be necessary to accurately identify these patients.
Compound 529064: Pyrrole, 1-(5-methylfurfuryl)

Chemical compound data from PubChem database. IUPAC Name: 1-[(5-methylfuran-2-yl)methyl]pyrrole. Molecular Formula: C10H11NO. Molecular Weight: 161.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527247: Khusene

Chemical compound data from PubChem database. IUPAC Name: 2,7,7-trimethyl-6-methylidenetricyclo[6.2.1.01,5]undecane. Molecular Formula: C15H24. Molecular Weight: 204.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
MAGPIE (Map Assisted Generation of Procedure and Intervention Encoding) [DEMO]

MAGPIE is an interactive tool to help users (e.g., professional coders, researchers, clinicians) find SNOMED CT and ICD-10-PCS codes for medical procedures and interventions. MAGPIE is an NLM research tool (it has not been tested in a production environment), and is developed primarily for the 2018 version of ICD-10-PCS. MAGPIE combines lexical and map-assisted searching strategies to look for SNOMED CT, ICD-9-CM, and ICD-10-PCS codes sequentially.
Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials

Background
          We would expect information on adverse drug reactions in randomised clinical trials to be easily retrievable from specific searches of electronic databases. However, complete retrieval of such information may not be straightforward, for two reasons. First, not all clinical drug trials provide data on the frequency of adverse effects. Secondly, not all electronic records of trials include terms in the abstract or indexing fields that enable us to select those with adverse effects data. We have determined how often automated search methods, using indexing terms and/or textwords in the title or abstract, would fail to retrieve trials with adverse effects data.
        
        
          Methods
          We used a sample set of 107 trials known to report frequencies of adverse drug effects, and measured the proportion that (i) were not assigned the appropriate adverse effects indexing terms in the electronic databases, and (ii) did not contain identifiable adverse effects textwords in the title or abstract.
        
        
          Results
          Of the 81 trials with records on both MEDLINE and EMBASE, 25 were not indexed for adverse effects in either database. Twenty-six trials were indexed in one database but not the other. Only 66 of the 107 trials reporting adverse effects data mentioned this in the abstract or title of the paper. Simultaneous use of textword and indexing terms retrieved only 82/107 (77%) papers.
        
        
          Conclusions
          Specific search strategies based on adverse effects textwords and indexing terms will fail to identify nearly a quarter of trials that report on the rate of drug adverse effects.